Clinical Report: Legacy of Prof. Jon van Rood in Transplantation Immunology
Overview
Prof. Jon van Rood, a pioneering figure in transplantation immunology and founder of key global donor registries, passed away at age 91. His groundbreaking discoveries in HLA antibodies and contributions to immunogenetics have shaped hematopoietic stem cell transplantation worldwide.
Background
Jon van Rood was a Dutch physician and immunologist who trained at Leiden University Medical Center, where he spent most of his career. He co-discovered HLA antibodies in the 1950s, a milestone that revolutionized transplantation medicine. He founded Bone Marrow Donors Worldwide and co-founded the World Marrow Donor Association, Eurotransplant, and other key organizations facilitating unrelated donor transplantation. His work extended over six decades, influencing both scientific understanding and clinical practice in histocompatibility and immunogenetics.
Data Highlights
Prof. van Rood’s contributions include the discovery of HLA antibodies, introduction of HLA typing into clinical practice, and pioneering use of computers to analyze serological data identifying early HLA alleles such as Bw4 and Bw6. His research on pregnancy-induced leukocyte antibodies and immune repertoires of mothers and children has informed transplantation outcomes. The EBMT Jon van Rood award recognizes outstanding junior investigators annually, highlighting his lasting impact on the field.
Key Findings
Co-discovery of HLA antibodies in the 1950s, foundational to transplantation immunology.
Founded Bone Marrow Donors Worldwide and co-founded the World Marrow Donor Association, facilitating global unrelated donor transplantation.
Introduced HLA typing into transfusion and transplantation medicine, improving donor-recipient matching.
Demonstrated that pregnancy induces leukocyte antibodies, influencing histocompatibility understanding.
Continued active scientific engagement until his death, focusing on immune repertoires affecting transplant outcomes.
Clinical Implications
Prof. van Rood’s work underpins modern histocompatibility testing and donor registry systems critical for successful hematopoietic stem cell transplantation. Understanding HLA compatibility and immune interactions between mother and child informs donor selection and transplant prognosis. His legacy supports ongoing advances in transplantation immunology and patient care worldwide.
Conclusion
Prof. Jon van Rood’s pioneering discoveries and leadership established the foundation for unrelated donor transplantation and immunogenetics. His enduring influence continues to inspire clinicians and researchers, improving outcomes for thousands of patients annually.
